ImmunityBio
IBRX
IBRX
47 hedge funds and large institutions have $6.47M invested in ImmunityBio in 2019 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 8 increasing their positions, 20 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
60% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 20
98% less call options, than puts
Call options by funds: $1K | Put options by funds: $53K
Holders
47
Holding in Top 10
–
Calls
$1K
Puts
$53K
Top Buyers
| 1 | +$814K | |
| 2 | +$286K | |
| 3 | +$127K | |
| 4 |
Jane Street
New York
|
+$92K |
| 5 |
Goldman Sachs
New York
|
+$79K |
Top Sellers
| 1 | -$1.37M | |
| 2 | -$404K | |
| 3 | -$394K | |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$318K |
| 5 |
DekaBank Deutsche Girozentrale
Frankfurt,
Germany
|
-$107K |